Rita Jain
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 5 boards, counting each seat separately. Longest: Celldex Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Celldex Therapeutics Inc. June 25, 202698.4%
-
AnaptysBio Inc. June 17, 202593.1%
-
Celldex Therapeutics Inc. June 5, 202599.6%
-
Celldex Therapeutics Inc. June 13, 202498.9%
-
Celldex Therapeutics Inc. June 15, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | First Tracks Biotherapeutics Inc. | Option exercise | +7,330 | — | — |
| Jun 15, 2025 | AnaptysBio Inc. | Option exercise | +7,330 | — | — |
| Jun 15, 2024 | AnaptysBio Inc. | Option exercise | +4,534 | — | — |
Questions about Rita Jain
What boards is Rita Jain on?
Rita Jain sits on the boards of AnaptysBio Inc., Avalo Therapeutics Inc., Celldex Therapeutics Inc., First Tracks Biotherapeutics Inc. and SAB Biotherapeutics Inc.
How long has Rita Jain served on boards?
Our records show at least 10 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.